Translational Science Interagency Fellowship Applications Close

First Deadline for Buck-IRB to Huron Transition

Deadlines and Key Dates for Buck-IRB to Huron Transition

After hearing feedback and to further ease the transition burden on researchers and ERIK team members, two data migrations will take place.

Any pending new study, amendment or continuing review submissions (e.g., incomplete, modifications required, deferred) in Buck-IRB will not be migrated into the Huron system. To allow time to complete screening IRB/exempt reviews in Buck-IRB and minimize the disruption to operations, migration will occur in two phases targeted for March 4 and March 21. The following are suggested dates to optimize chances for approval before the final migration - following these guidelines will help reduce the chances of starting the application process in Buck-IRB and missing the window for review, necessitating the need to submit the same application in Huron.

Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.

Dr. Julie Johnson, PI and Director of the CTSI, Presented at the 2024 Fall CTSA Annual Meeting

The Fall 2024 CTSA Program Annual Meeting brought together personnel from CTSA Program Hubs across the nation to network, share best practices and knowledge transfer.

Dr. Johnson opened the Friday session and discussed translational science principals, pilot programs and adjustments made to advance clinical and translational science in pilots.

Access Dr. Johnson's Slides

Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.

Preparing for 2025 NIH Application and Review Changes

Changes include:

Simplified Review Framework for Most Research Project Grant Applications
Revisions to the NIH Fellowship Application and Review Process
Updates to Institutional Training Grant Applications
Updates to Reference Letter Instructions for Referees
Updated Application Forms (FORMS-I)

Access Tips and Resources

Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.

CTSI Faculty Career Development Grants Information Session

How to Write an Impactful NIH R01/R21/R03 Grant: A Reviewer's Perspective

Tips From an Award-Winning Teacher: Creating Safe Spaces to Engage Learners with Alex Grieco

Grant Writing Office Hours

Subscribe to